临床与内镜特征对异时性结直肠进展期锯齿状病变发生的影响
本回顾性队列研究纳入2008至2019年间在三级中心接受超过1次门诊结肠镜检查的4990例成人,评估异时性进展期锯齿状病变(mASL)的临床与内镜预测因素。女性、主动吸烟、任何无蒂锯齿状病变(SSL)和传统锯齿状腺瘤(TSA)与mASL相关。基线SSL≥10 mm、SSL伴异型增生和TSA的5年累积发生率分别为26%、27%和18%,支持3年监测间隔;基线HP≥10 mm或3-4个SSL<10 mm者3年间隔可能比3-5年更合适。
要点
- 基线SSL≥10 mm、SSL伴异型增生、TSA的5年mASL累积发生率分别为26%、27%、18%,支持3年监测间隔。
- 基线HP≥10 mm或3-4个SSL<10 mm者5年累积发生率分别为17%和21%,3年间隔可能比3-5年更合适。
- 同步非进展期锯齿状病变和非进展期腺瘤与mASL无关。
核心结论
- 数据支持对基线SSL≥10 mm、SSL伴异型增生和TSA患者采用3年监测间隔的现行推荐。
- 对基线HP≥10 mm或3-4个SSL<10 mm患者,3年间隔可能比3-5年更合适。
- 同步非进展期锯齿状病变和非进展期腺瘤患者似乎未增加mASL风险。
研究设计与样本
- 回顾性队列研究,纳入2008至2019年间在三级中心接受超过1次门诊结肠镜检查的成人。
- 共纳入4990例患者,45.4%为女性,平均年龄60.9±9.2岁,中位随访时间3.7年。
- 锯齿状病变包括无蒂锯齿状病变(SSL)、传统锯齿状腺瘤(TSA)和增生性息肉(HP)。
- 采用Kaplan-Meier估计和Cox比例风险模型评估mASL的5年累积发生率和相关因素。
主要发现
- 女性性别和主动吸烟与mASL相关。
- 内镜下,任何SSL和TSA与mASL相关。
- mASL的5年累积发生率:SSL≥10 mm为26%(95%CI 18%-32%),HP≥10 mm为17%(95%CI 3.5%-29%),3-4个SSL<10 mm为21%(95%CI 0%-42%),TSA为18%(95%CI 0%-38%),SSL伴低级别异型增生为27%(95%CI 3.6%-45%)。
- 基线同步非进展期锯齿状病变和非进展期腺瘤与mASL无关。
关键数值与推荐
- 基线SSL≥10 mm、SSL伴异型增生和TSA:现行推荐3年监测间隔。
- 基线HP≥10 mm或3-4个SSL<10 mm:3年间隔可能比3-5年更合适。
- 基线同步非进展期锯齿状病变和非进展期腺瘤:似乎未增加mASL风险。
临床怎么用
- 对基线SSL≥10 mm、SSL伴异型增生和TSA患者,支持采用3年监测间隔。
- 对基线HP≥10 mm或3-4个SSL<10 mm患者,作者认为3年间隔可能比3-5年更合适。
- 对同步非进展期锯齿状病变和非进展期腺瘤患者,作者认为似乎未增加mASL风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: High-risk adenomas predict metachronous advanced adenomatous neoplasia. Limited data exist on predictors of metachronous advanced serrated lesions (mASLs). We analyzed clinical and endoscopic predictors of mASLs. METHODS: In this retrospective cohort study, adults with >1 outpatient colonoscopy between 2008 and 2019 at a tertiary center were included. Serrated lesions (SLs) included sessile SLs (SSLs), traditional serrated adenomas (TSAs), and hyperplastic polyps (HPs). Patient and endoscopic characteristics were obtained using electronic medical records. Five-year cumulative incidence of mASL (HP ≥10 mm, SSL ≥10 mm or with dysplasia, any TSA) and factors associated with mASL were evaluated using Kaplan-Meier estimates and Cox proportional hazards models. RESULTS: A total of 4990 patients were included and 45.4% were women. Mean age was 60.9 ± 9.2 years and median follow-up time was 3.7 years. Female sex and active smoking were associated with mASL. Endoscopically, any SSL and TSA were associated with mASL. The 5-year cumulative incidence for mASL was 26% (95% confidence interval [CI], 18%-32%) for SSL ≥10 mm, 17% (95% CI, 3.5%-29%) for HP ≥10 mm, 21% (95% CI, 0%-42%) for 3-4 SSLs <10 mm, 18% (95% CI, 0%-38%) for TSA, and 27% (95% CI, 3.6%-45%) for SSL with low-grade dysplasia. Baseline synchronous nonadvanced SL and nonadvanced adenoma were not associated with mASL. CONCLUSIONS: Our data support current recommendations for a 3-year surveillance interval in patients with baseline SSL ≥10 mm, SSL with dysplasia, and TSA. A 3-year interval may be more appropriate than 3-5 years for patients with baseline HP ≥10 mm or 3-4 SSLs <10 mm. Patients with synchronous nonadvanced SLs and adenomas do not appear to be at increased risk of mASL.
引用
- Rouphael C, El Halabi J, Bena J, et al. Impact of Clinical and Endoscopic Features on the Development of Metachronous Colorectal Advanced Serrated Lesions. Clin Gastroenterol Hepatol. 2023. PMID: 37544421. doi:10.1016/j.cgh.2023.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。